Add to ORKGBackground In India, TB and HIV co-infection remains as a serious public health problem. From 2006 onwards, the intensified TB-HIV collaborative activities are being jointly implemented by National AIDS Control Programme (NACP) and Revised National TB Control programme (RNTCP) at high HIV burden states. Objectives To determine (a) the predictors of outcome among a cohort of HIV-TB co-infected patients after two years after initiation of ART treatment. (b) prognostic significance of time difference between the initiation of ATT and ART in HIV-TB co-infected patients. Methods Patients registered at sixteen ART centres in Karnataka, from October through December 2009 formed the study cohort and were followed till December 2011. Results A total...
Background: Tuberculosis (TB) control efforts have been challenged by deadly interaction of TB and H...
Background Predicting the risk of tuberculosis (TB) in people living with HIV (PLHIV) using a single...
There is paucity of data from India on the impact of HIV related immunosuppression in response to TB...
In India, TB and HIV co-infection remains as a serious public health problem. From 2006 onwards, the...
In India, TB and HIV co-infection remains as a serious public health problem. From 2006 onwards, the...
Introduction: tuberculosis (TB) remains a public health problem and is driven by HIV. Recent studies...
Objectives : We evaluated the effect of the time interval between the initiation of antiretroviral t...
[7]. Patients with a CD4+ cell count less than 200 cells/mm3, should start ART as soon as Mozambique...
Copyright © 2013 Gerardo Alvarez-Uria et al. This is an open access article distributed under the Cr...
Introduction: tuberculosis (TB) remains a public health problem and is driven by HIV. Recent studies...
Background: Antiretroviral therapy (ART) should be given to all Human Immunodeficiency Virus (HIV)-p...
Background: Optimal timing for initiation of antiretroviral therapy (ART) among HIV-infected patient...
SETTING: Integrated HIV Care programme, Mandalay, Myanmar. OBJECTIVES: To determine time to starting...
Background Given the high death rate the first two months of tuberculosis (TB) therapy in HIV patien...
Background: Tuberculosis (TB) and the HIV epidemics have been well known previously but now these ar...
Background: Tuberculosis (TB) control efforts have been challenged by deadly interaction of TB and H...
Background Predicting the risk of tuberculosis (TB) in people living with HIV (PLHIV) using a single...
There is paucity of data from India on the impact of HIV related immunosuppression in response to TB...
In India, TB and HIV co-infection remains as a serious public health problem. From 2006 onwards, the...
In India, TB and HIV co-infection remains as a serious public health problem. From 2006 onwards, the...
Introduction: tuberculosis (TB) remains a public health problem and is driven by HIV. Recent studies...
Objectives : We evaluated the effect of the time interval between the initiation of antiretroviral t...
[7]. Patients with a CD4+ cell count less than 200 cells/mm3, should start ART as soon as Mozambique...
Copyright © 2013 Gerardo Alvarez-Uria et al. This is an open access article distributed under the Cr...
Introduction: tuberculosis (TB) remains a public health problem and is driven by HIV. Recent studies...
Background: Antiretroviral therapy (ART) should be given to all Human Immunodeficiency Virus (HIV)-p...
Background: Optimal timing for initiation of antiretroviral therapy (ART) among HIV-infected patient...
SETTING: Integrated HIV Care programme, Mandalay, Myanmar. OBJECTIVES: To determine time to starting...
Background Given the high death rate the first two months of tuberculosis (TB) therapy in HIV patien...
Background: Tuberculosis (TB) and the HIV epidemics have been well known previously but now these ar...
Background: Tuberculosis (TB) control efforts have been challenged by deadly interaction of TB and H...
Background Predicting the risk of tuberculosis (TB) in people living with HIV (PLHIV) using a single...
There is paucity of data from India on the impact of HIV related immunosuppression in response to TB...